Meeting NewsVideo

VIDEO: Presenter discusses trials to evaluate safety, efficacy of ALLN-177 for hyperoxaluria

SAN DIEGO — At ASN Kidney Week 2018, Annamaria T. Kausz, MD, MS, discussed two phase III trials that evaluated the safety and efficacy of ALLN-177 in patients with enteric hyperoxaluria.

SAN DIEGO — At ASN Kidney Week 2018, Annamaria T. Kausz, MD, MS, discussed two phase III trials that evaluated the safety and efficacy of ALLN-177 in patients with enteric hyperoxaluria.

    See more from American Society of Nephrology Annual Meeting